Tilray Brands Inc vs Vital Farms Inc — how do they compare? Tilray Brands Inc trades at $3.53 (market cap $530.54M), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: Tilray Brands Inc is the larger of the two by market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 1,810,837). Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Vital Farms Inc for 14 Days on average.
| TLRY | VITL | |
|---|---|---|
Market Cap | $530.54M | $405.27M |
Volume | 9,099,075 | 1,810,837 |
Sector | Health | Consumer Staples |
52-Week High | $21.00 | $43.68 |
52-Week Low | $3.57 | $8.28 |
Typical Hold Time | 31 Days | 14 Days |
Enterprise Value | $684.46M | $492.28M |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Vital Farms (VITL) trades at $9.24, down 1.7% on the day, reflecting ongoing pressure from weak earnings and industry headwinds. The stock shows a bearish technical trend with key support at $9.00, while fundamentals reveal a sharp decline in profitability with a net margin of just 0.02% in 2026. Recent news highlights strategic review discussions and institutional acquisitions, yet negative cash flow and pricing challenges in the egg market weigh on investor confidence.
The outlook remains cautious with significant execution risks amid industry oversupply, though analyst consensus suggests upside potential to a $13.11 price target. Investment opportunity hinges on a successful strategic review and margin recovery, but risks include sustained cash burn and competitive pressures that could limit near-term gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →